Cargando…

Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease

Synaptic dysfunction and loss is the strongest pathological correlate of cognitive decline in Alzheimer's disease (AD) with increasing evidence implicating neuropathological tau protein in this process. Despite the knowledge that tau spreads through defined synaptic circuits, it is currently un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickett, Eleanor K., Henstridge, Christopher M., Allison, Elizabeth, Pitstick, Rose, Pooler, Amy, Wegmann, Susanne, Carlson, George, Hyman, Bradley T., Spires‐Jones, Tara L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516127/ https://www.ncbi.nlm.nih.gov/pubmed/28196395 http://dx.doi.org/10.1002/syn.21965

Ejemplares similares

Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy
por: Kopeikina, Katherine J., et al.
Publicado: (2013)

Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets
por: Pooler, Amy M, et al.
Publicado: (2013)

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
por: Pooler, Amy M, et al.
Publicado: (2015)

Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease
por: Jackson, Rosemary J., et al.
Publicado: (2016)

Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model
por: Davies, Caitlin, et al.
Publicado: (2023)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses
por: Rudinskiy, Nikita, et al.
Publicado: (2014)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
por: Dai, Chun-ling, et al.
Publicado: (2018)

3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice
por: Fu, Hongjun, et al.
Publicado: (2016)

Alzheimer's disease: synapses gone cold
por: Koffie, Robert M, et al.
Publicado: (2011)

Oligomeric tau-targeted immunotherapy in Tg4510 mice
por: Schroeder, Sulana, et al.
Publicado: (2017)

Intersection of pathological tau and microglia at the synapse
por: Vogels, Thomas, et al.
Publicado: (2019)

LRP1 is a master regulator of tau uptake and spread
por: Rauch, Jennifer N., et al.
Publicado: (2020)

Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
por: Song, Lixin, et al.
Publicado: (2015)

Experimental evidence for the age dependence of tau protein spread in the brain
por: Wegmann, Susanne, et al.
Publicado: (2019)

Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease
por: Tai, Hwan-Ching, et al.
Publicado: (2014)

Tau protein liquid–liquid phase separation can initiate tau aggregation
por: Wegmann, Susanne, et al.
Publicado: (2018)

Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain
por: Takeda, Shuko, et al.
Publicado: (2015)

Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice
por: Anglada‐Huguet, Marta, et al.
Publicado: (2021)

Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
por: Mate De Gerando, Anastasie, et al.
Publicado: (2023)

Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers
por: Jackson, Rosemary J, et al.
Publicado: (2019)

Spreading of Tau Protein Does Not Depend on Aggregation Propensity
por: Rodrigues, Sara, et al.
Publicado: (2023)

Characterization of TauC3 antibody and demonstration of its potential to block tau propagation
por: Nicholls, Samantha B., et al.
Publicado: (2017)

Late neurodegeneration in the Tau transgenic mouse model rTg4510
por: Helboe, Lone, et al.
Publicado: (2013)

The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
por: Kent, Sarah A., et al.
Publicado: (2020)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Local Nucleation of Microtubule Bundles through Tubulin Concentration into a Condensed Tau Phase
por: Hernández-Vega, Amayra, et al.
Publicado: (2017)

Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
por: Rajamohamedsait, Hameetha, et al.
Publicado: (2017)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
por: Lau, Dawn H. W., et al.
Publicado: (2016)

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2020)

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
por: Diez, Lisa, et al.
Publicado: (2020)

Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
por: Caballero, Benjamin, et al.
Publicado: (2021)

LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
por: Lee, Daniel C, et al.
Publicado: (2010)

Genotype-Specific Differences between Mouse CNS Stem Cell Lines Expressing Frontotemporal Dementia Mutant or Wild Type Human Tau
por: Orr, Miranda E., et al.
Publicado: (2012)

Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons
por: Rodríguez-Martín, Teresa, et al.
Publicado: (2016)

Physiological release of endogenous tau is stimulated by neuronal activity
por: Pooler, Amy M, et al.
Publicado: (2013)

Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
por: Hastings, Nicholas B., et al.
Publicado: (2017)

Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
por: Saura, Carlos A, et al.
Publicado: (2023)

Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
por: Robbins, Miranda
Publicado: (2023)

Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer’s Disease
por: Pickett, Eleanor K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ne6vk7borf68og888tv0laal9u